- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04971915
The Effect of Minimalist Footwear on the Anthropometric and Biomechanical Parameters of the Lower Limb and Foot
The Effect of Minimalist Footwear on the Anthropometric and Biomechanical Parameters of the Lower Limb and Foot During Long-Term Wearing: A Randomized Clinical Trial
Study Overview
Detailed Description
The minimalist footwear represents an alternative style of footwear wearing, which could allow the foot to move more naturally compared to the footwear wearing in conventional footwear. That footwear is characterized by no cushioning, wide toe box, zero foot drop, thin sole (1,5 - 8 mm), low weight, and high flexibility of footwear. This study aims to determine the effect of 6months of wearing minimalist footwear on the foot and lower limb's anthropometric and biomechanical parameters.
The study is designed as a parallel interventional study. The sample size consists of 50 healthy individuals divided into experimental and control groups by randomization. All participants undergo the initial examination and baseline and final measurement focused on the foot anthropometry and kinetics and kinematics of the foot and lower limb during walking. Besides, the experimental group undergoes a 6months intervention of wearing minimalist footwear, during which the participants will record their movement behavior by electronic diary.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Olomouc, Czechia, 77111
- Faculty of Physical Culture, Palacky University Olomouc
-
Olomouc, Czechia, 77900
- Palacky University Olomouc, Faculty of Physical Culture
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy individuals
- Individuals without previous experience in wearing minimalist footwear
Exclusion Criteria:
- Significant deformities of the feet and toes
- Pain of the musculoskeletal system
- Injury, congenital or gained defect of the musculoskeletal or neural system in past
- Undergo operation of lower limbs in past or during research
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: minimalist footwear
The participants in the experimental group will receive one pair of minimalist footwear and will be asked to use them for the interventional period.
|
The intervention consists of wearing the minimalist footwear in recommended progression during the interventional period (6months).
The intial load starts at 2,500 steps a day and will be gradually increased up according to the participant´s tolerance rate to the footwear wearing to fully use over the final period.
Participants are instructed to report all issues and difficulties possibly connected to the intervention.
There will be the opportunity to consult any issue connected with footwear or their wearing through the duration of the research.
|
No Intervention: control
The participants in the control group will be asked to wear their standard footwear as before participating in the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle
Time Frame: at baseline and at the end of 6 months intervention
|
Range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in maximal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle
Time Frame: at baseline and at the end of 6 months intervention
|
Maximal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in minimal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle
Time Frame: at baseline and at the end of 6 months intervention
|
Minimal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in angular velocity of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle
Time Frame: at baseline and at the end of 6 months intervention
|
Angular velocity of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in walking velocity
Time Frame: at baseline and at the end of 6 months intervention
|
Walking velocity will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in walking cadence
Time Frame: at baseline and at the end of 6 months intervention
|
Walking cadence will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in step length during walking
Time Frame: at baseline and at the end of 6 months intervention
|
Step length will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in duration of stance phase of the gait cycle
Time Frame: at baseline and at the end of 6 months intervention
|
Duration of stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in maximum value of the vertical component of ground reaction force during walking
Time Frame: at baseline and at the end of 6 months intervention
|
Maximum value of the vertical component of ground reaction force will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in minimum value of the vertical component of ground reaction force during walking
Time Frame: at baseline and at the end of 6 months intervention
|
Minimum value of the vertical component of ground reaction force will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in impulse of the vertical component of ground reaction force during walking
Time Frame: at baseline and at the end of 6 months intervention
|
Impulse of the vertical component of ground reaction force will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in lower limbs joints moments during walking
Time Frame: at baseline and at the end of 6 months intervention
|
Lower limbs joints moments will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain).
|
at baseline and at the end of 6 months intervention
|
Change in peak plantar pressure at anatomical regions of the foot sole during walking
Time Frame: at baseline and at the end of 6 months intervention
|
Peak plantar pressure at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium).
|
at baseline and at the end of 6 months intervention
|
Change in contact time at anatomical regions of the foot sole during walking
Time Frame: at baseline and at the end of 6 months intervention
|
Contact time at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium).
|
at baseline and at the end of 6 months intervention
|
Change in contact area at anatomical regions of the foot sole during walking.
Time Frame: at baseline and at the end of 6 months intervention
|
Contact area at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium).
|
at baseline and at the end of 6 months intervention
|
Change in pressure-time integral at anatomical regions of the foot sole during walking
Time Frame: at baseline and at the end of 6 months intervention
|
Pressure-time integral at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium).
|
at baseline and at the end of 6 months intervention
|
Change in maximum force at anatomical regions of the foot sole during walking
Time Frame: at baseline and at the end of 6 months intervention
|
Maximum force at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium).
|
at baseline and at the end of 6 months intervention
|
Change in foot length
Time Frame: at baseline and at the end of 6 months intervention
|
Foot length will be measured by RSS 3D Scanner (RSScan International NV, Paal, Belgium).
|
at baseline and at the end of 6 months intervention
|
Change in foot width
Time Frame: at baseline and at the end of 6 months intervention
|
Foot width will be measured by RSS 3D Scanner (RSScan International NV, Paal, Belgium).
|
at baseline and at the end of 6 months intervention
|
Change in tactile-foot perception
Time Frame: at baseline and at the end of 6 months intervention
|
Tactile-foot perception will be measured by Baseline Tactile Monofilaments (Fabrication Enterprises, White Plains, NY, USA).
|
at baseline and at the end of 6 months intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Lenka Murinova, Faculty of Physical Culture, Palacky University Olomouc
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IGA_FTK_2021_010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Footwear
-
High Point UniversityAdidas International, Inc.CompletedFoot | FootwearUnited States
-
University GhentCompletedSports Injury | Risk Factor | FootwearBelgium
-
University of SalfordCompletedOsteoarthritis, Knee | Meniscus Injury | FootwearUnited Kingdom
Clinical Trials on minimalist footwear
-
University of LiegeEnrolling by invitationWounds and Injuries | Running | Oxygen ConsumptionBelgium
-
Hospital Israelita Albert EinsteinRecruitingEvaluation of the Minimalist Music and Birdsongs in the Anxiety of Nursing Professionals in OncologyAnxiety Disorders and SymptomsBrazil
-
Staffordshire UniversityIndia Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes HospitalsCompletedDiabetes Complications | Diabetic NeuropathiesIndia
-
High Point UniversityAdidas International, Inc.CompletedFoot | FootwearUnited States
-
Universidad Complutense de MadridCompletedDiabetic Foot | Diabetic Foot UlcerSpain
-
VA Office of Research and DevelopmentUniversity of Nebraska; Results Group LLCRecruiting
-
University of AarhusAarhus University HospitalCompleted
-
Universidade do AlgarveUniversity of Huelva; OKM Química Ortopédica S.L.; Lola - J. Andrade Ferreira... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Diabetic Peripheral NeuropathyPortugal
-
University of VirginiaNot yet recruitingPlantar Fascitis | Plantar Fasciopathy | Plantar Fasciitis, Chronic | Plantar Fasciitis of Both Feet | Plantar Fasciitis of Right Foot | Plantar Fasciitis of Left FootUnited States
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder